Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men?
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Because primary aldosteronism is not uncommon, specifically treatable and in some cases curable, and carries higher risks for cardiovascular morbidity and mortality than essential hypertension, screening hypertensive patients for its presence by measuring aldosterone to renin ratio (ARR) is increasingly common. A significantly higher false-positive ARR rate for women than men, resulting in unnecessary suppression tests has previously been reported. METHODS: Using a new, highly accurate aldosterone assay and both of the currently widely used renin assays, ARR was measured in 19 normal, ovulating women at three time points in the menstrual cycle and compared with single measurements in 21 normal males of similar age. RESULTS: ARRs in males were possibly too well down in the current normal range. Although normotensive and normokalemic, two women had raised ARRs in the luteal phase but only when direct renin concentration (DRC) was used. Their DRC levels were low at all sampling times [despite midrange plasma renin activity levels], whereas their progesterone and aldosterone levels were highest for the group. Saline suppression testing, performed in one of them, showed normal aldosterone suppressibility. CONCLUSION: False-positive ARRs in normal women during the luteal phase only when DRC is used may explain the higher incidence of false-positive ARRs in hypertensive women than men and suggest the following: 1) plasma renin activity is preferable to DRC in determination of ARR and 2) new reference ranges for ARR that take into account gender and sex hormone levels are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Primary aldosteronism: renaissance of a syndrome
Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02775.x · Cited by 680
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., & Rutherford, J. C. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02519.x · Cited by 496
Self-citationDrug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., & Veglio, F. (2002) · Hypertension · doi:10.1161/01.hyp.0000038478.59760.41 · Cited by 392
Renin angiotensin system and gender differences in the cardiovascular system
Fischer, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00479-5 · Cited by 384
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
Oelkers, W. K. H. (1996) · Steroids · doi:10.1016/0039-128x(96)00007-4 · Cited by 333
Guo, T., Taylor, R. L., Singh, R. J., & Soldin, S. J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.034 · Cited by 227
Vogeser, M., & Parhofer, K. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-981458 · Cited by 176
Conception and pharmacodynamic profile of drospirenone
Elger, W. A. G., Beier, S., Pollow, K., Garfield, R. E., Shi, S. Q., & Hillisch, A. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.008 · Cited by 157
Cited by
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 159
“We reported luteal concentrations of plasma aldosterone, DRC, and PRA to be higher than follicular in 19 healthy, normotensive females (12).”
BackgroundSelf-citationRossi, G. P., Bisogni, V., Bacca, A., Belfiore, A., Cesari, M., Concistrè, A., Pinto, R. D., Fabris, B., Fallo, F., Fava, C., et al. (2020) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2020.100029 · Cited by 147
Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids
Keevil, B. G. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.015 · Cited by 154
Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement
Young, W. F., Calhoun, D. A., Lenders, J. W. M., Stowasser, M., & Textor, S. C. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00054 · Cited by 144
Self-citationMetabolomics and Incident Hypertension Among Blacks: The Atherosclerosis Risk in Communities Study
Zheng, Y., Yu, B., Alexander, D. C., Mosley, T. H., HEISS, G. M., Nettleton, J. A., & Boerwinkle, E. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01166 · Cited by 109
“cells, indirect effects mediated by humoral factors,(28) as well as modifying aldosterone, renin, and aldosterone to renin ratio.(39)”
BackgroundPimenta, E. (2011) · Hypertension Research · doi:10.1038/hr.2011.190 · Cited by 121
Self-citationAhmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2918 · Cited by 89
Self-citationLaboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Hundemer, G. L., Leung, A. A. C., Kline, G. A., Brown, J. M., Turcu, A. F., & Vaidya, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad024 · Cited by 97
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis
Gómez-Sánchez, E. P. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.014 · Cited by 84
“Progesterone is a competitive MR antagonist that is inactivated by several enzymes in aldosterone target renal epithelial cells [22], but attains sufficient concentrations during pregnancy and the luteal phase of the estrus cycle in species with distinct luteal and follicular phases to inhibit MR, leading to renin-ang…”
BackgroundMeasurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism
Guo, Z., Poglitsch, M., McWhinney, B. C., Ungerer, J. P. J., Ahmed, A. H., Gordon, R. D., Wolley, M. J., & Stowasser, M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa001 · Cited by 78
Self-citationGuo, Z., Poglitsch, M., McWhinney, B. C., Ungerer, J. P. J., Ahmed, A. H., Gordon, R. D., Wolley, M. J., & Stowasser, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01041 · Cited by 72
Self-citationGPER-1 and Estrogen Receptor-β Ligands Modulate Aldosterone Synthesis
Caroccia, B., Seccia, T. M., Campos, A. G., Gioco, F., Kuppusamy, M., Ceolotto, G., Guerzoni, E., Simonato, F., Mareso, S., Lenzini, L., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1416 · Cited by 70
Ng, E., Gwini, S. M., Libianto, R., Choy, K. W., Lu, Z. X., Shen, J., Doery, J. C. G., Fuller, P. J., & Yang, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac568 · Cited by 65
Pathophysiology and genetics of salt-sensitive hypertension
Maaliki, D. S., Itani, M. M., & Itani, H. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1001434 · Cited by 67
“, 2018), primary aldosteronism (Ahmed et al., 2011), and obesity (Goodfriend et al.”
BackgroundKerstens, M. N., Kobold, A. C. M., Volmer, M., Koerts, J., Sluiter, W. J., & Dullaart, R. P. F. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165662 · Cited by 55
“Concerns have been raised that the ARRprc is more likely to produce a false-positive test result in women than the ARRpra (10, 11).”
BackgroundResultThe multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
“Primary Aldosteronism (PA) in premenopausal women (8).”
Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?
Gómez-Sánchez, E. P. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000329 · Cited by 63
Changes in biochemical tests in pregnancy and their clinical significance
Teasdale, S., & Morton, A. (2018) · Obstetric Medicine · doi:10.1177/1753495x18766170 · Cited by 57
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
Mullen, N., Curneen, J. M. G., Donlon, P. T., Prakash, P., Bancos, I., Gurnell, M., & Dennedy, M. C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad026 · Cited by 56
Ahmed, A. H., Calvird, M., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., Young, R. M., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2603 · Cited by 55
“To avoid the potential for cyclical estrogen and progesterone changes to confound results (32), we evaluated, for the first time, the effect of SSRI on ARR in depressed, normotensive male patients.”
BackgroundSelf-citationToering, T. J., Gant, C. M., Visser, F. W., van der Graaf, A. M., Laverman, G. D., Danser, A. H. J., Faas, M. M., Navis, G., & Lely, A. T. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00109.2017 · Cited by 52
“This is in contrast to earlier studies, which describe a lower plasma renin in premenopausal women than in men (1, 11).”
BackgroundResultSFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps
Douillard, C., Houillier, P., Nussberger, J., & Girerd, X. J. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.02.003 · Cited by 50
Chen, J., Gomez-Sanchez, C. E., Penman, A., May, P. J., & Gomez-Sanchez, E. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00506.2013 · Cited by 48
“parallel to progesterone throughout the normal estrous cycle and pregnancy to maintain normal MR occupancy by aldosterone in aldosterone target cells, thus ensuring fluid, electrolyte and cardiovascular homeostasis (1, 30, 53).”
Guo, Z., Poglitsch, M., Cowley, D., Domenig, O., McWhinney, B. C., Ungerer, J. P. J., Wolley, M. J., & Stowasser, M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14871 · Cited by 50
Self-citationPotential effects of age on screening for primary aldosteronism
Luo, Q., Li, N.-F., Yao, X.-G., Zhang, D. L., Abulikemu, S.-F.-Y., Chang, G., Zhou, K.-M., Wang, G.-L., Wang, M. H., Ouyang, W.-J., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.21 · Cited by 45
Camenzind, A. G., van der Gugten, J. G., Popp, R., Holmes, D. T., & Borchers, C. H. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-20 · Cited by 39
“Moreover, aldosterone:PRC may suffer from a higher false-positive rate in women [19].”
BackgroundJuutilainen, A., Savolainen, K., Romppanen, J., Turpeinen, U., Hämäläinen, E. K., Kemppainen, J., Moilanen, L., & Pulkki, K. J. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.015 · Cited by 38
Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism
Mulatero, P., Bertello, C., Veglio, F., & Monticone, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac460 · Cited by 38
Carter, S., Owen, L. J., Kerstens, M. N., Dullaart, R. P. F., & Keevil, B. G. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.011186 · Cited by 35
The use of mass spectrometry to improve the diagnosis and the management of the HPA axis
Monaghan, P. J., Keevil, B. G., & Trainer, P. J. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9240-1 · Cited by 28
Glinicki, P., Jeske, W., Papierska, L., Kruszyńska, A., Gietka‐Czernel, M., Rosłonowska, E., Slowinska-Srzednicka, J., Kasperlik-Zaluska, A. A., & Zgliczyński, W. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313519487 · Cited by 32
Age‐ and sex‐specific reference ranges are needed for the aldosterone/renin ratio
Solanki, P., Gwini, S. M., Doery, J. C. G., Choy, K. W., Shen, J., Young, M. J., Fuller, P. J., & Yang, J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14199 · Cited by 31
Ahmed, A. H., Gordon, R. D., Ward, G., Wolley, M. J., McWhinney, B. C., Ungerer, J. P. J., & Stowasser, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3851 · Cited by 32
“We also found changing hormone levels during the normal menstrual cycle to be associated with differing effects on PRA and DRC, and hence on ARR, with the likelihood of false-positive ratios again being much greater with DRC than with PRA (26).”
BackgroundSelf-citationDiagnostic Delay and Disease Burden in Primary Aldosteronism: An International Patient Survey
Ananda, R. A., Gwini, S. M., Long, K. M., Lai, J. H., Chen, G., Russell, G. M., Stowasser, M., Fuller, P. J., & Yang, J. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21965 · Cited by 34
Self-citationAhmed, A. H., Gordon, R. D., Ward, G., Wolley, M. J., Kogovsek, C., & Stowasser, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12705 · Cited by 29
Self-citationFunder, J. W. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0119 · Cited by 36
Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism
Schilbach, K., Junnila, R. K., & Bidlingmaier, M. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0672-0836 · Cited by 38
“Nonetheless, there may be individual cases in which significant changes of the ARR occur throughout the menstrual cycle: In a study with healthy women, 2 out of 19 had an increased ARR in the luteal phase if PRC was used to calculate the ARR [26].”
BackgroundMethodBurrello, J., Amongero, M., Buffolo, F., Sconfienza, E., Forestiero, V., Burrello, A., Adolf, C., Handgriff, L., Reincke, M., Veglio, F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa974 · Cited by 29
Karashima, S., Kometani, M., Tsujiguchi, H., Asakura, H., Nakano, S., Usukura, M., Mori, S., Ohe, M., Sawamura, T., Okuda, R., et al. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1339072 · Cited by 31
“(39) reported a significantly higher falsepositive ARR rate for women than men resulting in unnecessary suppression tests when renin is measured as direct renin concentration and not PRA.”
BackgroundStowasser, M., Ahmed, A. H., Guo, Z., Wolley, M. J., Ungerer, J. P. J., McWhinney, B. C., Poglitsch, M., & Gordon, R. D. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-121468 · Cited by 25
“These observations suggest that PRA may be preferable to DRC in determination of ARR and new reference ranges for ARR may be required, which take into account gender and sex hormone levels [20].”
BackgroundMethodInfluentialSelf-citationEffect of Moxonidine on the Aldosterone/Renin Ratio in Healthy Male Volunteers
Ahmed, A. H., Gordon, R. D., Ward, G., Wolley, M. J., McWhinney, B. C., Ungerer, J. P. J., & Stowasser, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3821 · Cited by 26
Self-citationO’Shea, P. M., Brady, J. J., Gallagher, N., Dennedy, M. C., & Fitzgibbon, M. C. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215603401 · Cited by 24
“The significance is that false-positive ARRs have been found in normal women tested during the luteal phase of their menstrual cycle when renin concentration is used.(16,41) The ARR, used as the primary screening tool for PA, is a highly variable test with sensitivity ranging from 70 to 80% and specificity ranging fro…”
Sex differences in hypertension. Do we need a sex-specific guideline?
Cífková, R., & Strilchuk, L. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.960336 · Cited by 33
The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges
O’Shea, P. M., Griffin, T. P., Denieffe, S., & Fitzgibbon, M. C. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13353 · Cited by 24
El-Asmar, N., Rajpal, A., & Arafah, B. M. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.007 · Cited by 26
Yang, J., Gwini, S. M., Beilin, L. J., Schlaich, M. P., Stowasser, M., Young, M. J., Fuller, P. J., & Mori, T. A. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17336 · Cited by 20
Self-citationImmunohistochemistry of the adrenal in primary aldosteronism
Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000248 · Cited by 21
“APCC scores were higher in normal adrenals from women [9 && ]; however women, particularly those who are premenopausal, produce more aldosterone [40,41].”
BackgroundFaulkner, J., Lluch, E., Kennard, S., Antonova, G. N., Jaffe, I. Z., & de Chantemèle, E. J. B. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00340-5 · Cited by 19
Diagnosing endocrine hypertension: a practical approach
Yang, J., Shen, J., & Fuller, P. J. (2017) · Nephrology · doi:10.1111/nep.13078 · Cited by 22
New Advances in the Diagnostic Workup of Primary Aldosteronism
Wolley, M. J., & Stowasser, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1107 · Cited by 20
Self-citationFaulkner, J., Harwood, D., Kennard, S., Antonova, G. N., Clere, N., & de Chantemèle, E. J. B. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00413.2020 · Cited by 17
“Women characteristically exhibit higher aldosterone levels than men in several pathological states, such as salt-sensitive hypertension (12), primary aldosteronism (13), and obesity (14).”
BackgroundVeldhuizen, G. P., Alnazer, R. M., Kroon, A. A., & de Leeuw, P. W. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14117 · Cited by 18
Yin, Y., Ma, C., Yu, S., Ai, Q., Han, C., Zhong, J., Luo, W., Ma, X., Yu, J., Zhang, Y., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117325 · Cited by 16
Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio
the Chongqing Primary Aldosteronism Study(CONPASS) Group, Shu, X., Mei, M., Ma, L., Wang, Z., Yang, S., Hu, J., Song, Y., He, W., Luo, T., et al. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0069-7 · Cited by 16
“premenopausal women during the luteal phase, which may explain the higher incidence of false-positive ARRs in hypertensive women than men in some degree [7].”
BackgroundStandard −20 °C freezer storage protocols may cause substantial plasma renin cryoactivation
Bonnitcha, P., Rigdwell, M., Ward, P., & Chesher, D. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1190 · Cited by 16
Alnazer, R. M., Veldhuizen, G. P., de Leeuw, P. W., & Kroon, A. A. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003377 · Cited by 13
“We expect this to not have a significant influence on the validity of the results as no significant difference in the ARR between the follicular and luteal phases has been reported [3,4].”
BackgroundResultPizzolo, F., Zorzi, F., Chiecchi, L., Consoli, L., Aprili, I., Guarini, P., Castagna, A., Salvagno, G. L., Pavan, C., & Olivieri, O. (2013) · Endocrine · doi:10.1007/s12020-013-0028-6 · Cited by 13
Aldosterone Excess and Resistant Hypertension: Investigation and Treatment
Stowasser, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0439-7 · Cited by 12
Self-citationScreening for primary aldosteronism using the newly developed IDS-iSYS® automated assay system
O’Shea, P. M., Griffin, T. P., Browne, G. A., Gallagher, N., Brady, J. J., Dennedy, M. C., Bell, M., Wall, D., & Fitzgibbon, M. C. (2016) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2016.11.002 · Cited by 13
“[38,39] This serves to illustrate the importance of understanding the clinical and biochemical context of the tests being interpreted and in particular the influence of medications.”
BackgroundGafane-Matemane, L. F., Mokae, N. L., Breet, Y., Poglitsch, M., & Schutte, A. E. (2020) · Hypertension Research · doi:10.1038/s41440-020-00566-1 · Cited by 11
Doan, T. B., Cheung, V., Clyne, C. D., Hilton, H. N., Eriksson, N. A., Young, M. J., Funder, J. W., Muscat, G. E. O., Fuller, P. J., Clarke, C. L., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01355-x · Cited by 12
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio
Lőcsei, Z., Horvath, D. E., Rácz, K., Szabolcs, I., Kovács, G. L., & Toldy, E. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.06.025 · Cited by 12
“A higher rate of falsely positive ARR in women than men has been previously reported [8] and explained by the elevation of plasma aldosterone levels in the luteal phase [8], suggesting that plasma aldosterone is menstrual cycle dependent.”
BackgroundPułapki w diagnostyce incydentaloma nadnerczy
Cyrańska-Chyrek, E., Grzymisławska, M., & Ruchała, M. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0028 · Cited by 32
“Therefore, separate norms in terms of aldosterone, PRA, and ARR are recommended not only for men and women, but also for separate menstrual cycle phases [42].”
BackgroundPamporaki, C., Remde, H., Constantinescu, G. A., Kürzinger, L., Fuß, C. T., Fuld, S., Peitzsch, M., Schulze, M., Alessi, F., Lee, M., et al. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004098 · Cited by 11
“The twice as many females as males in whom primary aldoste-ronism was excluded and who underwent confirmatory tests likely reflects the higher rates of false-positive false-positive results for the ARR in women than men [36].”
Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population
Grytaas, M. A., Strømsøy, S., Rørvik, J. T., Arnes, J. B., Heie, A., Arnesen, T., Jørstad, M. D., Nedrebø, B. G., Jøssang, D. E., Jensen, D., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-118909 · Cited by 9
Kline, G. A., & Chin, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803412-5.00005-7 · Cited by 10
Aldosterone-producing adenoma associated with non-suppressed renin: a case series
Jansen, P. M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00525-4 · Cited by 7
“For example, both renin and aldosterone concentrations increase in the luteal phase of the menstrual cycle but aldosterone increases disproportionally, resulting in a rise in ARR [33].”
BackgroundSelf-citationZhang, W., Wang, Y., Wei, Z. C., Chang, G., Luo, Q., Abudusailamu, N., Nurula, M., Tao, S., Li, H., & Chen, Y. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_9 · Cited by 5
Primary aldosteronism: Aldosterone/renin ratio cut-off points
Russmann, M. L. E., Delfino, L., Fierro, F., Santoro, S., Peréz, M., Caruso, G., Glikman, P., Gauna, A., & Lupi, S. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.11.016 · Cited by 6
“As a result, it has been used on a routine basis and for a number of years by international reference centers with extensive experience in the field.(7,13,14) Rossi et al.”
Ng, E., Gwini, S. M., Stowasser, M., Young, M. J., Fuller, P. J., Singh, G., & Yang, J. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.52062 · Cited by 5
Self-citationCao, L., Gu, B., Yao, L., Li, G., Wang, C., Cui, H., Xu, R., & Wang, H. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0587 · Cited by 3
Zhang, Q., Zhao, Z., Cheng, W., Zhang, Y., Li, Z., Liu, H., Chunxia, X., & Wang, K. (2024) · Endocrine · doi:10.1007/s12020-024-03899-w · Cited by 4
“Estrogen can increase the secretion of angiotensinogen and reduce the concentration of renin and aldosterone but has no effect on renin activity [23].”
Primary Aldosteronism and Drug Resistant Hypertension: A “Chicken-Egg” Story
Lenzini, L., Pintus, G., Rossitto, G., Seccia, T. M., & Rossi, G. P. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2073-3202 · Cited by 3
“Lastly, aldosterone excess could be due to causes other than PA, such as obesity, menopause, and genetic polymorphisms, which contribute to resistance to antihypertensive therapy [58, 59].”
BackgroundPlasma and serum prorenin concentrations in diabetes, hypertension, and renal disease
Kawamura, S., Fujimoto, K., Hayashi, A., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00959-4 · Cited by 3
“PRA values fluctuate greatly depending on blood sampling conditions, such as posture [1], sodium/water intake [2], female menstrual cycle [3, 4], time of day [5], endogenous angiotensinogen levels [6], and medication use [7].”
BackgroundThe Aldosterone–Renin Ratio: Role and Problems
Stowasser, M., & Gordon, R. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_9 · Cited by 4
“We measured the ARR in 19 normal, ovulating women at three time points in the menstrual cycle and compared it with single measurements in 21 normal males of similar age [ 3 ].”
BackgroundMethodSelf-citationZhang, C., Guo, Z., Yi, C., Wang, H., Zhang, W., & Zhao, Y. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01006-8 · Cited by 3
Zhong, J., Ma, X., Wang, D. X., Luo, W., Yin, Y., Zou, Y., Zhu, Y., Li, M., Xie, S., Ss, Y., et al. (2026) · Journal of Chromatography B · doi:10.1016/j.jchromb.2026.124930 · Cited by 2
Guzelce, E. C., Wong, K. Y. H., Heydarpour, M., Pojoga, L. H., Romero, J. R., Williams, J. S., Adler, G. K., Seely, E. W., & Williams, G. H. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae871 · Cited by 4
Challenges in Endocrinology Testing
Bazydlo, L. A. L., Harris, N., & Winter, W. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415783-5.00011-6 · Cited by 4
Hiperaldosteronismo primario: puntos de corte del cociente aldosterona/renina
Russmann, M. L. E., Delfino, L., Fierro, F., Santoro, S., Peréz, M., Caruso, G., Glikman, P., Gauna, A., & Lupi, S. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.11.008 · Cited by 5
Amar, L., & Azizi, M. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.07.029 · Cited by 2
Primary Aldosteronism; Epidemiology and Screening
Stowasser, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64331-3 · Cited by 2
Self-citationFuld, S., Yang, J., Constantinescu, G. A., Pamporaki, C., Alessi, F., Peitzsch, M., Schulze, M., Brüdgam, D., Remde, H., Kürzinger, L., et al. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-1670 · Cited by 1
“Females have a particularly high risk for false-positive results for the ARR, leading to a more frequent requirement for con fi rmatory tests [13, 14].”
Challenges in endocrinology testing
Jacobsen, L. M., Bazydlo, L. A. L., Harris, N., & Winter, W. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813776-5.00011-x · Cited by 2
Hormone Interactions in Endometrial Cancer
Kamal, A. M., Tempest, N., Maclean, A., Adishesh, M., Bhullar, J., Makrydima, S. F., & Hapangama, D. K. (2019) · Springer eBooks · doi:10.1007/978-3-319-64513-1_6 · Cited by 1
Lalić, T. (2013) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1348044l
Primary aldosteronism as an endocrinological challenge – old doubts and new diagnostic possibilities
Cyrańska-Chyrek, E., Grzymisławska, M., & Ruchała, M. (2016) · Journal of Medical Science · doi:10.20883/jms.2016.104
Ateş, C., Gül, A. D. A., Sarıdaş, F. M., et al. (2022) · Turkish Journal of Internal Medicine · doi:10.46310/tjim.1072050
Veldhuizen, G. P., Alnazer, R. M., Kroon, A. A., et al. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-024-00926-1
“In another study, the ARR did rise from the follicular to the luteal phase when a direct renin concentration (DRC) was used to measure renin but not when plasma renin activity (PRA) was used to calculate the ARR [7].”
(2000) · Time to knit · doi:10.1016/s2211-9698(21)43482-5
Primary aldosteronism; epidemiology and screening
Stowasser, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00157-6
Self-citationBaharuddin, N. (2025) · Springer eBooks · doi:10.1007/978-981-97-7640-5_53 · Cited by 1
Epidemiology and the Need for Screening
Gordon, R. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_2
“It would (1) make diagnosis of unilateral PA diffi cult or impossible, reducing the quality of outcome for up to onethird of patients; (2) make prevalence permanently unknowable; (3) make deciding the appropriate dosage of aldosterone antagonist impossible when interfering medications are also being taken and (4) carr…”
BackgroundSelf-citation
Metadata
- Authors
- Ahmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M.
- Affiliations
- The University of Queensland (AU)
- Sullivan Nicolaides Pathology (AU)
- Corresponding author
- Stowasser, Michael
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-02
- Volume
- 96
- Issue
- 2
- Pages
- E340-E346
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1988501908
- Cited by
- 96
- References
- 29
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 3 · 2020: 10 · 2019: 7 · 2018: 5 · 2017: 13 · 2016: 5 · 2015: 4 · 2014: 11 · 2013: 7 · 2012: 2
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, aldosterone-renin ratio, false-positive screening results, sex differences, menstrual cycle, luteal phase, progesterone, plasma renin activity, reference values, hypertension screening
- MeSH terms
- Adult, Aldosterone, Mineralocorticoid Receptor Antagonists, Chromatography, High Pressure Liquid, False Positive Reactions, Female, Follicle Stimulating Hormone, Humans, Hydrocortisone, Hyperaldosteronism, Immunoassay, Male, Menstrual Cycle, Progesterone, Renin, Sex Characteristics, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.